Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Cohtrol Program: Comparisons of colonoscopy and FOBT/FIT based screening

被引：35

作者：

Subramanian, Sujha ^{[1
]}

Tangka, Florence K. L. ^{[2
]}

Hoover, Sonja ^{[1
]}

Royalty, Janet ^{[2
]}

DeGroff, Amy ^{[2
]}

Joseph, Djenaba ^{[2
]}

机构：

[1] RTI Int, 307 Waverley Oaks Rd,Suite 101, Waltham, MA 02452 USA

[2] Ctr Dis Control & Prevent, Div Canc Prevent & Control, 4770 Buford Highway NE,Mailstop K-76, Atlanta, GA 30341 USA

来源：

EVALUATION AND PROGRAM PLANNING | 2017年 / 62卷

关键词：

Screening cost; Activity-based costing; Economic evaluation; Colorectal cancer screening; NATIONAL BREAST; UNITED-STATES; GUIDELINES; LESSONS;

D O I：

10.1016/j.evalprogplan.2017.02.007

中图分类号：

C [社会科学总论];

学科分类号：

030301 [社会学];

摘要：

We assess annual costs of screening provision activities implemented by 23 of the Centers for Disease Control and Prevention's Colorectal Cancer Control Program (CRCCP) grantees and report differences in costs between colonoscopy and FOBT/FIT-based screening programs. We analysed annual cost data for the first three years of the CRCCP (July 2009-June 2011) for each screening provision activity and categorized them into clinical and non-clinical screening provision activities. The largest cost components for both colonoscopy and FOBT/FIT-based programs were screening and diagnostic services, program management, and data collection and tracking. During the first 3 years of the CRCCP, the average annual clinical cost for screening and diagnostic services per person served was $1150 for colonoscopy programs, compared to $304 for FIT/FOBT-based programs. Overall, FOBT/FIT-based programs appear to have slightly higher non-clinical costs per person served (average $1018: median $838) than colonoscopy programs (average $980: median $686). Colonoscopy-based CRCCP programs have higher clinical costs than FOBT/FIT-based programs during the 3-year study timeframe (translating into fewer people screened). Non-clinical costs for both approaches are similarand substantial. Future studies of the cost-effectiveness of colorectal cancer screening initiatives should consider both clinical and non-clinical costs.(C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：73 / 80

页数：8

共 25 条

[1]

[Anonymous], 2007, COST EFFECTIVENESS D

[2]

Drummond MF, 2005, Methods for The Economic Evaluation of Health Care Programmes

[3]

Cost of Services Provided by the National Breast and Cervical Cancer Early Detection Program [J].

Ekwueme, Donatus U. ;

Subramanian, Sujha ;

Trogdon, Justin G. ;

Miller, Jacqueline W. ;

Royalty, Janet E. ;

Li, Chunyu ;

Guy, Gery P., Jr. ;

Crouse, Wesley ;

Thompson, Hope ;

Gardner, James G. .

CANCER, 2014, 120 (16) :2604-2611

[4]

Cutting cost and increasing access to colorectal cancer screening: Another approach to following the guidelines [J].

Fisher, JA ;

Fikry, C ;

Troxel, AB .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) :108-113

[5]

Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881

[6]

National Colorectal Cancer Roundtable, TOOLS RES 80 SCREEN

[7]

National Governors Association Center for Best Practices, 2008, STAT STRAT CURB COL

[8]

Pignone Michael., 2005, EC MODELS COLORECTAL

[9]

American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 [J].

Rex, Douglas K. ;

Johnson, David A. ;

Anderson, Joseph C. ;

Schoenfeld, Phillip S. ;

Burke, Carol A. ;

Inadomi, John M. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (03) :739-750

[10]

Sabatino SA, 2015, MMWR-MORBID MORTAL W, V64, P464

← 1 2 3 →